Statin therapy and erythropoiesis-stimulating agent hyporesponsiveness in patients with nondialysis chronic kidney disease: A retrospective study in Beijing, China

Erythropoiesis-stimulating agents (ESAs) are frequently used among patients with renal anemia, while a significant proportion of patients exhibit ESA hyporesponsiveness despite adequate dosing. Previous studies have suggested an inverse association between ESA hyporesponsiveness and statin use among...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Zhun, Wang, Mi, Zuo, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336583/
https://www.ncbi.nlm.nih.gov/pubmed/30633179
http://dx.doi.org/10.1097/MD.0000000000013981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336583/
https://www.ncbi.nlm.nih.gov/pubmed/30633179
http://dx.doi.org/10.1097/MD.0000000000013981

Ejemplares similares